These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 37124886

  • 1. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.
    Luo SH, Zhou MM, Cai MJ, Han SL, Zhang XQ, Chu JG.
    World J Gastroenterol; 2023 Apr 21; 29(15):2336-2348. PubMed ID: 37124886
    [Abstract] [Full Text] [Related]

  • 2. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH, Chu JG, Huang H, Zhao GR, Yao KC.
    World J Gastroenterol; 2019 Mar 07; 25(9):1088-1099. PubMed ID: 30862997
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
    Lin ZP, Chen SL, Wang JY, Liu F, Tan Q, Peng QF, Zhao JB.
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug 20; 28(8):672-678. PubMed ID: 32911906
    [Abstract] [Full Text] [Related]

  • 4. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Aug 20; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Outcomes of Transjugular Intrahepatic Portosystemic Shunt and Gastric Coronary Vein Embolization for Variceal Bleeding in Cirrhotic Portal Hypertension.
    Mukhiya G, Han X, Jiao D, Bi Y, Pokhrel G, Liu Z, Li Z, He Y.
    Clin Med Res; 2023 Sep 20; 21(3):144-154. PubMed ID: 37985166
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial.
    Riggio O, Ridola L, Angeloni S, Cerini F, Pasquale C, Attili AF, Fanelli F, Merli M, Salvatori FM.
    J Hepatol; 2010 Aug 20; 53(2):267-72. PubMed ID: 20537753
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F, Jepsen P, Amanavicius N, Aagaard NK.
    Scand J Gastroenterol; 2019 Jul 20; 54(7):899-904. PubMed ID: 31203699
    [Abstract] [Full Text] [Related]

  • 11. Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt.
    Luo SH, Chu JG, Huang H, Yao KC.
    World J Gastroenterol; 2017 Jul 14; 23(26):4779-4787. PubMed ID: 28765699
    [Abstract] [Full Text] [Related]

  • 12. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
    Grønbaek H, Astrup LB, Nielsen DT, Vilstrup H.
    Ugeskr Laeger; 2003 Jan 27; 165(5):439-42. PubMed ID: 12599838
    [Abstract] [Full Text] [Related]

  • 13. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M, Prodehl L, Ede CJ.
    Cochrane Database Syst Rev; 2018 Oct 31; 10(10):CD001023. PubMed ID: 30378107
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC.
    J Hepatol; 1995 Aug 31; 23(2):123-8. PubMed ID: 7499782
    [Abstract] [Full Text] [Related]

  • 16. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F, Baez AL, Pandula R, Walser E, Lau DT.
    J Gastroenterol Hepatol; 2005 Mar 31; 20(3):474-81. PubMed ID: 15740494
    [Abstract] [Full Text] [Related]

  • 17. [Preliminary application of transjugular intrahepatic portosystemic shunt in individualized treatment of patients with cirrhotic portal hypertension complicated with refractory ascites and variceal hemorrhage].
    Jiang MM, Xu H, Zhang QQ, Wei N, Xu W, Cui YF, Liu HT, Zu MH, Wang WL, Gao ZK.
    Zhonghua Yi Xue Za Zhi; 2019 Dec 17; 99(47):3737-3740. PubMed ID: 31874500
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.